首頁生技醫藥生技製藥

2023 Taiwan Industrial Outlook—Pharmaceutical Industry

2000元/點
字數 3937
頁數 13
出版作者 ITIS Research Team, Industrial Information Group, DCB
出版單位 生物技術開發中心
出版日期 2023/12/06
出版類型 產業評析
所屬領域 生技製藥
瀏覽次數 600
加入購物車 直接下載 直接下載 加入最愛
摘要

In 2022, the COVID-19 pandemic continued to impact the global economy. Congestion at major global ports and lockdown measures in Mainland China have plunged the pharmaceutical industry into a crisis of supply chain disruptions. Meanwhile, the war in Ukraine and the sanctions imposed on Russia by various countries have triggered abrupt increases in the price of natural gas, oil, and food, exacerbating global inflation. These dynamics have persistently increased pharmaceutical expenditures across major global markets, prompting regulatory agencies worldwide to intensify the implementation of drug pricing and cost control mechanisms in an effort to curb the growth of the pharmaceutical market. According to data from Fitch Solutions, the size of the global pharmaceutical market in 2022 was approximately US$ 1.4 trillion, a 2.0% growth compared to 2021. The Compound Annual Growth Rate (CAGR) from 2018 to 2022 was 4.6%.

內文標題/表標題

I、Definition and Scope of Industry

II、Development of Pharmaceutical Industry in 2022

III、Key Market

IV、Future Outlook for Global Pharmaceutical Industry

Table 1 Classification of Pharmaceutical-related Industries in Taiwan

上一篇韓國電商市場發展現況
下一篇AI於食品產業的破壞式創新與變...
熱門點閱
推薦閱讀
推薦新聞

若有任何問題,可使用下方檢索互動介面找解答,或是寫信到客服信箱。

itismembers@iii.org.tw

星期一~五
9:00-12:30/13:30-18:00